Despite the recent progress that has been made in the understanding and treatment of acute lymphoblastic leukemia (ALL), the outcome is still dismal in adult ALL cases. Several studies in solid tumors identified high expression of WEE1 kinase as a poor prognostic factor and reported its role as a cancer-conserving oncogene that protects cancer cells from DNA damage. Therefore, the targeted inhibition of WEE1 kinase has emerged as a rational strategy to sensitize cancer cells to antineoplastic compounds, which we evaluate in this study.

Targeting WEE1 to enhance conventional therapies for acute lymphoblastic leukemia

Ghelli Luserna Di Rorà, Andrea;Imbrogno, Enrica;Ferrari, Anna;Robustelli, Valentina;Righi, Simona;Sabattini, Elena;Testoni, Nicoletta;Baldazzi, Carmen;Papayannidis, Cristina;Abbenante, Maria Chiara;Marconi, Giovanni;Paolini, Stefania;Parisi, Sarah;Sartor, Chiara;Fontana, Maria Chiara;Iacobucci, Ilaria;Cavo, Michele;Martinelli, Giovanni
2018

Abstract

Despite the recent progress that has been made in the understanding and treatment of acute lymphoblastic leukemia (ALL), the outcome is still dismal in adult ALL cases. Several studies in solid tumors identified high expression of WEE1 kinase as a poor prognostic factor and reported its role as a cancer-conserving oncogene that protects cancer cells from DNA damage. Therefore, the targeted inhibition of WEE1 kinase has emerged as a rational strategy to sensitize cancer cells to antineoplastic compounds, which we evaluate in this study.
Ghelli Luserna Di Rorà, Andrea; Beeharry, Neil; Imbrogno, Enrica; Ferrari, Anna; Robustelli, Valentina; Righi, Simona; Sabattini, Elena; Verga Falzacappa, Maria Vittoria; Ronchini, Chiara; Testoni, Nicoletta; Baldazzi, Carmen; Papayannidis, Cristina; Abbenante, Maria Chiara; Marconi, Giovanni; Paolini, Stefania; Parisi, Sarah; Sartor, Chiara; Fontana, Maria Chiara; De Matteis, Serena; Iacobucci, Ilaria; Pelicci, Pier Giuseppe; Cavo, Michele; Yen, Timothy J; Martinelli, Giovanni
File in questo prodotto:
File Dimensione Formato  
document(1).pdf

accesso aperto

Tipo: Versione (PDF) editoriale
Licenza: Licenza per Accesso Aperto. Creative Commons Attribuzione (CCBY)
Dimensione 6.65 MB
Formato Adobe PDF
6.65 MB Adobe PDF Visualizza/Apri

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: http://hdl.handle.net/11585/649310
Citazioni
  • ???jsp.display-item.citation.pmc??? 16
  • Scopus 25
  • ???jsp.display-item.citation.isi??? 23
social impact